Jason Amello - Chief Financial Officer at Candel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
CADL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jason Amello since 10/6/2023

Holdings reported by Jason Amello for Candel Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 202K $182K $0.90 Nov 28, 2023 Direct
Stock Option (Right to Buy) 90K Apr 28, 2023 Direct Common Stock

Transactions reported by Jason Amello for Candel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.